6:07 AM ET
8-K
Shareholder Meeting
Onconetix Shareholder Meeting
Onconetix, Inc. held its 2026 Annual Meeting of Stockholders on November 10, 2026, where shareholders approved all five proposals. Key outcomes included the election of Josh Epstein as a Class II director, the ratification of MaloneBailey, LLP as auditors, and the grant of discretionary authority to the Board to effect a reverse stock split at a ratio between 1-for-2 and 1-for-15.